skip to the main content
Contact Us
Go Search
Go Search Menu

Infliximab

Monitors a pharmacokinetics of infliximab-treated patients

AFIAS Infliximab tests measures the level of infliximab in blood and provide pharmacokinetic information. It helps to monitor patients with potentially subtherapeutic level and optimize the individual regimen.

  • CE AFIAS

Available Instruments

AFIAS-1 AFIAS-6

About Using Reagent

  • Sample Types

    plasma, serum, and whole blood (only general mode)

  • Reaction Time

    10mins (AFIAS)

  • Detection Range

    AFIAS 0.2~50 μg/mL

  • Indication

    Therapeutic drug monitoring (TDM), Pharmacokinetics

In Your Medical Field

AFIAS Infliximab test detects the level of infliximab with a small amount of human serum, plasma, or whole blood in less than 10min. This test provides information regarding the patients’ response towards the treatment of infliximab and based on result physicians can decide the appropriate infliximab regimen.